The Coyotes have been working with a neurologist on a new medication for players with labyrinthiasis and the team is hoping to be ready for their season opener in the NHL next month.
In a statement Thursday, Burke said he is hopeful the team will be ready in time for a home opener in early September.
The Coyotes announced the news at a news conference on Thursday.
“We have been using a medication developed by Dr. Thomas J. Pnes, MD, that has shown some promise to help alleviate the symptoms of the disease,” Burke said in the statement.
“It is not perfect, but it is working.”
The team said it would not be making any further comment on the medication.
The team has already started using a new treatment, the ZM-1, but the team has not disclosed when it will start using that medication.
Burke said the team had been using the medication for the last three weeks and has been doing “excellent” and “good” work.
The medication is expected to be in the Coyotes’ care by mid-September.
Pnes is best known for developing and testing the treatment.
He was an assistant professor at Yale University before joining the New York-Presbyterian Hospital-Cornell Medical Center.
He is also the head of the Center for Neurodegenerative Disease Research.
“I have been on a mission to develop a drug for the treatment of neurodegeneration for many years,” he said in a statement.
“For this, I have received much gratitude and much support.
I am pleased to be able to continue to work on this important work.”
Pnes said his team has been working on the treatment since April and has tested the medication twice.
He said he hopes to begin clinical trials for the drug in the coming months.
The ZM2, which has not been approved by the Food and Drug Administration, is a newer drug, meaning it has not received FDA approval yet.
It is used to treat a number of conditions including Parkinson’s disease and amyotrophic lateral sclerosis, a neurological condition that damages nerve cells in the spinal cord.
Pnez said in his statement that he was “deeply saddened” to learn about the diagnosis and that he is grateful for the support the Coyotes have received from the community.
He also thanked those who have donated to help pay for the medication and his family.